SEARCH

SEARCH BY CITATION

References

  • Ancoli-Israel, S., Walsh, J. K., Mangano, R. M. and Fujimori, M. Z. A Novel nonbenzodiazepine hypnotic, effectively treats insomnia in elderly patients without causing rebound effects Primary Care Companion. J. Clin. Psychiatry, 1999, 1: 114120.
  • Anton-Tay, F., Diaz, J. L. and Fernandez-Guardiola, A. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sci., 1971, 10: 841850.
  • Arendt, J., Bojkowski, C., Franey, C., Wright, J. and Marks, V. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine:abolition of the urinary 24-hour rhythm with atenolol. J. Clin. Endocrinol. Metab., 1985, 60: 11661173.
  • Barchas, J., Dacosta, F. and Spector, S. Acute pharmacology of melatonin. Nature, 1967, 214: 919920.
  • Baskett, J. J., Broad, J. B., Wood, P. C., Duncan, J. R., Pledger, M. J., English, J. and Arendt, J. Does melatonin improve sleep in older people? A randomised crossover trial Age Ageing, 2003, 32: 164170.
  • Bastien, C. H., LeBlanc, M., Carrier, J. and Morin, C. M. Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines. Sleep, 2003, 26: 313317.
  • Bellon, A. Searching for new options for treating insomnia: are melatonin and ramelteon beneficial? J. Psychiatr. Pract., 2006, 12: 229243.
  • Chesson, A., Hartse, K., Anderson, W. M., Davilla, D., Johnson, S., Littner, M., Wise, M. and Rafecas, J. Practice parameters for the evaluation of chronic insomnia. Sleep, 2000, 23: 237241.
  • Costae Silva, J., Chase, M., Sartorius, N. and Roth, T. Special report from a symposium held by the world health organization and the world federation of sleep research societies: an overview of insomnia and related disorders: recognition, epidemiology and rational management. Sleep, 1996, 19: 412416.
  • Cramer, H., Rudolph, J., Consbruch, U. and Kendel, K. On the effects of melatonin on sleep and behavior in man. Adv. Biochem. Psychopharmacol., 1974, 11: 187191.
  • Dement, W. C., Miles, L. E. and Carskadon, M. A. ‘White paper’ on sleep and aging. J. Am. Geriatr. Soc., 1982, 30: 2550.
  • DSM-IV, American psychiatric association diagnostic and statistical manual of mental disorders. 4th edn., DSM-IV, Washington DC, 1994.
  • Garfinkel, D., Laudon, M., Nof, D. and Zisapel, N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet, 1995, 346: 541544.
  • Glass, J., Lanctot, K. L., Herrmann, N., Sproule, B. A. and Busto, U. E. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ, 2005, 19: 11691176.
  • Gorfine, T. and Zisapel, N. Melatonin and the human hippocampus: a time dependent interplay. J. Pineal. Res., 2007, 43: 8086.
  • Gorfine, T., Assaf, Y., Goshen-Gottstein, Y., Yeshurun, Y. and Zisapel, N. Sleep-anticipating effects of melatonin in the human brain. Neuroimage, 2006, 31: 410418.
  • Gorfine, T., Yeshurun, Y. and Zisapel, N. Nap and melatonin-induced changes in hippocampal activation and their role in verbal memory consolidation. J. Pineal. Res., 2007 (in press).
  • Haimov, I., Lavie, P., Laudon, M., Herer, P., Vigder, C. and Zisapel, N. Melatonin replacement therapy of elderly insomniacs. Sleep, 1995, 18: 598603.
  • Haimov, I., Laudon, M., Zisapel, N., Souroujon, M., Nof, D., Herer, P., Tzischinsky, O. and Lavie, P. Sleep disorders and melatonin rhythms in elderly people. BMJ, 1994, 309: 167.
  • Haimov, I., Lavie, P., Laudon, M., Herer, P., Vigder, C. and Zisapel, N. Melatonin replacement therapy of elderly insomniacs. Sleep, 1995, 18: 598603.
  • Hajak, G. Epidemiology of severe insomnia and its consequences in Germany. Eur. Arch. Psychiatry Clin. Neurosci., 2001, 251: 4956.
  • Hughes, R. J., Sack, R. and Lewy, A. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep, 1998, 21: 5268.
  • Kieser, M., Rohmel, J. and Friede, T. Power and sample size determination when assessing the clinical relevance of trial results by ‘responder analyses’. Stat. Med., 2004, 23: 32873305.
  • Krystal, A. D. The changing perspective on chronic insomnia management. J. Clin. Psychiatry, 2004, 65(Suppl.) 8: 2025.
  • Krystal, A. D. Treating the health, quality of life, and functional impairments in insomnia. J. Clin. Sleep. Med., 2007, 3: 6372.
  • Laudon, M., Nir, I. and Zisapel, N. Melatonin receptors in discrete brain areas of the male rat. Neuroendocrinology, 1988, 48: 577583.
  • Leger, D., Laudon, M. and Zisapel, N. Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am. J. Med., 2004, 116: 9195.
  • Lewy, A. J. The dim light melatonin onset, melatonin assays and biological rhythm reseach in humans. Biol. Signals Recept., 1999, 8: 7983.
  • Littner, M., Hirshkowitz, M., Kramer, M., Kapen, S., Anderson, W. M., Bailey, D., Berry, R. B., Davila, D., Johnson, S., Kushida, C., Loube, D. I., Wise, M. and Woodson, B. T. Practice parameters for using polysomnography to evaluate insomnia: an update. Sleep, 2003, 26: 754760.
  • Mendelson, W. B. A review of the evidence for the efficacy and safety of trazodone in insomnia. J. Clin. Psychiatry, 2005, 66: 469476.
  • Morin, C. M. Measuring outcomes in randomized clinical trials of insomnia treatments. Sleep Med. Rev., 2003, 7: 263279.
  • Nugent, A. M., Gleadhill, I., McCrum, E., Patterson, C. C., Evans, A. and MacMahon, J. Sleep complaints and risk factors for excessive daytime sleepiness in adult males in Northern Ireland. J. Sleep Res., 2001, 10: 6974.
  • Ohayon, M. Epidemiological study on insomnia in the general population. Sleep, 1996, 19: S7S15.
  • Ohayon, M. and Zulley, J. Correlates of global sleep dissatisfaction in the German population. Sleep, 2001, 24: 780787.
  • Ohayon, M. M., Zulley, J., Guilleminault, C., Smirne, S. and Priest, R. G. How age and daytime activities are related to insomnia in the general population: consequences for older people. J. Am. Geriatr. Soc., 2001, 49: 360366.
  • Parrott, A. C. and Hindmarch, I. Factor analysis of a sleep evaluation questionnaire. Psychol. Med., 1978, 8: 325329.
  • Paul, M. A., Gray, G., Kenny, G. and Pigeau, R. A. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance. Aviat. Space Environ. Med., 2003, 74: 12631270.
  • Paul, M. A., Gray, G., Maclellan, M. and Pigeau, R. A. Sleep-inducing pharmaceuticals: a comparison of melatonin, zaleplon, zopiclone, and temazepam. Aviat. Space Environ. Med., 2004a, 75: 512519.
  • Paul, M. A., Gray, G., Sardana, T. M. and Pigeau, R. A. Melatonin and zopiclone as facilitators of early circadian sleep in operational air transport crews. Aviat. Space Environ. Med., 2004b, 75: 439443.
  • Reiter, R. J. The melatonin rhythm: both a clock and a calendar. Experientia, 1993, 49: 654664.
  • Riedel, B. W. and Lichstein, K. L. Objective sleep measures and subjective sleep satisfaction: how do older adults with insomnia define a good night’s sleep? Psychol. Aging, 1998, 13: 159163.
  • Riemann, D., Fischer, J., Mayer, G. and Peter, H. J. The guidelines for ‘non-restorative sleep’: relevance for the diagnosis and therapy of insomnia. Die Leitlinie “Nicht-erholsamer Schlaf”: Relevanz für Diagnostik und Therapie der Insomnie. Somnologie, 2003, 7: 6676.
  • Rodenbeck, A., Huether, G. and Hajak, G. Sleep disorders and aging: understanding the causes. In: Y.Touitou (ed) Biological Clocks. Mechanisms and Applications Elsevier Edition, Vol. 1. Elsevier, Amsterdam, 1998: 329332.
  • Rombaut, N., Maillard, F., Kelly, F. and Hindmarch, I. The quality of life of insomniacs questionnaire (QOLI). Med. Sci. Res., 1990, 18: 845847.
  • Roth, T., Roehrs, T., Costa e Silva, J. A. and Chase, M. H. Public Health and Insomnia: consensus statement regarding its status and needs for future action. Sleep, 1999, 22: 417420.
  • Roth, T., Hajak, G. and Ustun, T. B. Consensus for the pharmacological management of insomnia in the new millennium. Int. J. Clin. Pract., 2001, 55: 4252.
  • Roth, T., Seiden, D., Sainati, S., Wang-Weigand, S., Zhang, J. and Zee, P. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med., 2006, 7: 312318.
  • Sateia, M. J., Doghramji, K., Hauri, P. J. and Morin, C. M. Evaluation of chronic insomnia. An American Academy of Sleep Medicine review. Sleep, 2000, 23: 243308.
  • Scharf, M. B., Mayleben, D. W., Kaffeman, M., Krall, R. and Ochs, R. Dose response effects of zolpidem in normal geriatric subjects. J. Clin. Psychiatry, 1991, 52: 7783.
  • Szabadi, E. Drugs for sleep disorders: mechanisms and therapeutic prospects. Br. J. Clin. Pharmacol., 2006, 61: 761766.
  • Tarrasch, R., Laudon, M. and Zisapel, N. Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients. Hum. Psychopharmacol., 2003, 18: 603610.
  • Tyrer, P., Murphy, S. and Riley, P. The benzodiazepine withdrawal symptom questionnaire. J. Affect. Disord., 1990, 19: 5361.
  • Vgontzas, A. N., Bixler, E. O., Wittman, A. M., Zachman, K., Lin, H. M., Vela-Bueno, A., Kales, A. and Chrousos, G. P. Middle-aged men show higher sensitivity of sleep to the arousing effects of corticotropin-releasing hormone than young men: clinical implications. J. Clin. Endocrinol. Metab., 2001, 86: 14891495.
  • Waldhauser, F., Waldhauser, M., Lieberman, H. R., Deng, M. H., Lynch, H. J. and Wurtman, R. J. Bioavailability of oral melatonin in humans. Neuroendocrinology, 1984, 39: 307313.
  • Wesensten, N. J., Balkin, T. J., Reichardt, R. M., Kautz, M. A., Saviolakis, G. A. and Belenky, G. Daytime sleep and performance following a zolpidem and melatonin cocktail. Sleep, 2005, 28: 93103.
  • Witt-Enderby, P. A., Bennett, J., Jarzynka, M. J., Firestine, S. and Melan, M. A. Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci., 2003, 72: 21832198.
  • World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva, WHO, 1992.
  • Wurtman, R. J. and Zhdanova, I. Improvement of sleep quality by melatonin. Lancet, 1995, 346: 1491.
  • Zammit, K. G., Weiner, J., Damato, N., Sillup, P. G. and McMillan, A. C. Quality of life in people with insomnia. Sleep, 1999, 22: S379S385.
  • Zeitlhofer, J., Schmeiser-Rieder, A., Tribl, G., Rosenberger, A., Bolitschek, J., Kapfhammer, G., Saletu, B., Katschnig, H., Holzinger, B., Popovic, R. and Kunze, M. Sleep and quality of life in the Austrian population. Acta Neurol. Scand., 2000, 102: 249257.
  • Zhdanova, I. V., Wurtman, R. J., Regan, M. M., Taylor, J. A., Shi, J. P. and Leclair, O. U. Melatonin treatment for age-related insomnia. J. Clin. Endocrinol. Metab., 2001, 86: 47274730.
  • Zisapel, N. The use of melatonin for the treatment of insomnia. Biol. Signals Recept., 1999, 8: 8489.
  • Zisapel, N. Sleep and sleep disturbances: biological basis and clinical implications. Cell Mol. Life Sci., 2007, 64: 11741186.
  • Zisapel, N. and Laudon, M. Subjective assessment of the effects of CNS-active drugs on sleep by the Leeds sleep evaluation questionnaire: a review. Hum. Psychopharmacol. Clin. Exp., 2002, 17: 119.
  • Zisapel, N. and Nir, T. Determination of the minimal clinically significant difference on a patient visual analog sleep quality scale. J. Sleep Res., 2003, 12: 291298.
  • Zisapel, N., Tarrasch, R. and Laudon, M. The relationship between melatonin and cortisol rhythms: clinical implications of melatonin therapy. Drug Dev. Res., 2005, 65: 119125.